BR9508033A - Cassete de expressão de dna vetor de expressão de levedura célula de levedura processo para produzir um polipeptídeo em levedura - Google Patents
Cassete de expressão de dna vetor de expressão de levedura célula de levedura processo para produzir um polipeptídeo em leveduraInfo
- Publication number
- BR9508033A BR9508033A BR9508033A BR9508033A BR9508033A BR 9508033 A BR9508033 A BR 9508033A BR 9508033 A BR9508033 A BR 9508033A BR 9508033 A BR9508033 A BR 9508033A BR 9508033 A BR9508033 A BR 9508033A
- Authority
- BR
- Brazil
- Prior art keywords
- yeast
- polypeptide
- dna
- codable amino
- produce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK70594 | 1994-06-16 | ||
US28285294A | 1994-07-29 | 1994-07-29 | |
PCT/DK1995/000249 WO1995034666A1 (en) | 1994-06-16 | 1995-06-16 | Synthetic leader peptide sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9508033A true BR9508033A (pt) | 1999-06-29 |
Family
ID=26064490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9508033A BR9508033A (pt) | 1994-06-16 | 1995-06-16 | Cassete de expressão de dna vetor de expressão de levedura célula de levedura processo para produzir um polipeptídeo em levedura |
Country Status (20)
Country | Link |
---|---|
US (2) | US5639642A (pt) |
EP (1) | EP0763117B1 (pt) |
JP (1) | JP3676369B2 (pt) |
KR (1) | KR100251054B1 (pt) |
CN (1) | CN1115413C (pt) |
AT (1) | ATE208823T1 (pt) |
AU (1) | AU693569B2 (pt) |
BR (1) | BR9508033A (pt) |
CZ (1) | CZ290069B6 (pt) |
DE (1) | DE69523915T2 (pt) |
DK (1) | DK0763117T3 (pt) |
ES (1) | ES2168367T3 (pt) |
FI (1) | FI965005A (pt) |
HU (1) | HU221118B1 (pt) |
MX (1) | MX9606492A (pt) |
NO (1) | NO965362L (pt) |
PL (1) | PL317722A1 (pt) |
PT (1) | PT763117E (pt) |
UA (1) | UA40648C2 (pt) |
WO (1) | WO1995034666A1 (pt) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
ZA9610456B (en) * | 1995-12-20 | 1997-06-20 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
WO1998026080A1 (en) * | 1996-12-13 | 1998-06-18 | Chiron Corporation | Method for expression of heterologous proteins in yeast |
ES2258797T3 (es) * | 1996-12-20 | 2006-09-01 | Novo Nordisk A/S | Proteinas con extension n-terminal expresadas en la levadura. |
AU5549998A (en) | 1997-01-24 | 1998-08-18 | Novo Nordisk A/S | Synthetic leader peptide sequences |
CA2205076A1 (en) | 1997-05-14 | 1998-11-14 | Jim Hu | Episomal expression cassettes for gene therapy |
AU2149899A (en) | 1998-01-23 | 1999-08-09 | Novo Nordisk A/S | Process for making desired polypeptides in yeast |
WO2001049870A1 (en) | 1999-12-29 | 2001-07-12 | Novo Nordisk A/S | Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
US20050100991A1 (en) * | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP1278544A4 (en) * | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | ALBUMIN FUSION PROTEINS |
CA2446739A1 (en) * | 2001-05-25 | 2002-12-05 | Human Genome Sciences, Inc. | Chemokine beta-1 fusion proteins |
WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2002364587A1 (en) * | 2001-12-21 | 2003-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
WO2003060071A2 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
GB0217033D0 (en) * | 2002-07-23 | 2002-08-28 | Delta Biotechnology Ltd | Gene and polypeptide sequences |
WO2005047508A1 (en) | 2003-11-14 | 2005-05-26 | Novo Nordisk A/S | Processes for making acylated insulin |
EP1692168B1 (en) | 2003-12-03 | 2011-07-20 | Novo Nordisk A/S | Single-chain insulin |
KR101184391B1 (ko) * | 2004-02-09 | 2013-03-14 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
US7527947B2 (en) * | 2004-06-14 | 2009-05-05 | Novozymes A/S | Signal peptide for producing a polypeptide |
US9056921B2 (en) | 2005-08-16 | 2015-06-16 | Novo Nordisk A/S | Method for making mature insulin polypeptides |
CA2566267A1 (en) * | 2005-12-09 | 2007-06-09 | University Health Network | Thymidylate kinase mutants and uses thereof |
US20090068158A1 (en) * | 2005-12-09 | 2009-03-12 | Medin Jeffrey A | Thymidylate kinase mutants and uses thereof |
DE602007009496D1 (de) | 2006-02-27 | 2010-11-11 | Novo Nordisk As | Insulinderivate |
AU2007219615B2 (en) | 2006-03-03 | 2013-11-28 | Promis Neurosciences Inc. | Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
WO2008034881A1 (en) | 2006-09-22 | 2008-03-27 | Novo Nordisk A/S | Protease resistant insulin analogues |
ES2464282T3 (es) | 2006-09-27 | 2014-06-02 | Novo Nordisk A/S | Método para preparar polipéptidos de insulina madura |
CA2584494A1 (en) * | 2007-03-27 | 2008-09-27 | Jeffrey A. Medin | Vector encoding therapeutic polypeptide and safety elements to clear transduced cells |
ES2654303T3 (es) | 2007-05-04 | 2018-02-13 | University Health Network | Inmunoterapia de IL-12 contra el cáncer |
WO2008139496A1 (en) * | 2007-05-16 | 2008-11-20 | Bigtec Private Limited | Recombinant human insulin and a method thereof |
JP5688969B2 (ja) | 2007-07-16 | 2015-03-25 | ノボ・ノルデイスク・エー/エス | プロテアーゼに対して安定しているペグ化インスリンアナログ |
WO2009115469A1 (en) | 2008-03-18 | 2009-09-24 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
US8568709B2 (en) * | 2008-03-20 | 2013-10-29 | University Health Network | Thymidylate kinase fusions and uses thereof |
WO2011064282A1 (en) | 2009-11-25 | 2011-06-03 | Novo Nordisk A/S | Method for making polypeptides |
CN102791730A (zh) | 2010-01-22 | 2012-11-21 | 诺沃—诺迪斯克有限公司 | 低度o-糖基化的fgf21的制备方法 |
RU2460795C1 (ru) * | 2011-07-06 | 2012-09-10 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП "ГосНИИгенетика") | Способ микробиологического синтеза секретируемого соматотропина человека и штамм дрожжей saccharomyces cerevisiae - продуцент секретируемого соматотропина человека |
EP2920319B1 (en) | 2012-11-16 | 2020-02-19 | Poseida Therapeutics, Inc. | Site-specific enzymes and methods of use |
WO2014088836A1 (en) | 2012-12-03 | 2014-06-12 | Merck Sharp & Dohme Corp. | O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues |
CN105308067B (zh) | 2013-06-07 | 2020-07-24 | 诺和诺德股份有限公司 | 制备成熟胰岛素多肽的方法 |
JP6275847B2 (ja) | 2014-02-28 | 2018-02-07 | ノヴォ ノルディスク アー/エス | アルファ接合因子プロペプチドバリアント |
US20170151281A1 (en) | 2015-02-19 | 2017-06-01 | Batu Biologics, Inc. | Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer |
US10562951B2 (en) | 2015-03-10 | 2020-02-18 | Merck Sharp & Dohme Corp. | Process for preparing recombinant insulin using microfiltration |
ES2886599T3 (es) | 2015-06-17 | 2021-12-20 | Poseida Therapeutics Inc | Composiciones y métodos para dirigir proteínas a loci específicos en el genoma |
CN105418755A (zh) * | 2015-12-28 | 2016-03-23 | 珠海冀百康生物科技有限公司 | 速效胰岛素前体蛋白以及速效胰岛素的制备方法 |
WO2019126578A1 (en) | 2017-12-20 | 2019-06-27 | Poseida Therapeutics, Inc. | Compositions and methods for directing proteins to specific loci in the genome |
US20210032307A1 (en) * | 2018-02-09 | 2021-02-04 | Jiangsu Hengrui Medicine Co., Ltd. | Codon optimized precursor gene and signal peptide gene of human insulin analogue |
CA3197423A1 (en) | 2020-11-04 | 2022-05-12 | Daniel Getts | Engineered chimeric fusion protein compositions and methods of use thereof |
MX2023010916A (es) | 2021-03-17 | 2023-12-14 | Myeloid Therapeutics Inc | Composiciones de proteinas de fusion quimericas modificadas por ingenieria y metodos de uso de las mismas. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340772C (en) * | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
US5037743A (en) * | 1988-08-05 | 1991-08-06 | Zymogenetics, Inc. | BAR1 secretion signal |
DK300090D0 (da) * | 1990-12-19 | 1990-12-19 | Novo Nordisk As | Fremgangsmaade til fremstilling af leadersekvenser |
-
1995
- 1995-06-06 US US08/468,674 patent/US5639642A/en not_active Expired - Lifetime
- 1995-06-16 AT AT95922439T patent/ATE208823T1/de not_active IP Right Cessation
- 1995-06-16 ES ES95922439T patent/ES2168367T3/es not_active Expired - Lifetime
- 1995-06-16 KR KR1019960707199A patent/KR100251054B1/ko not_active IP Right Cessation
- 1995-06-16 DE DE69523915T patent/DE69523915T2/de not_active Expired - Lifetime
- 1995-06-16 AU AU27334/95A patent/AU693569B2/en not_active Ceased
- 1995-06-16 JP JP50150496A patent/JP3676369B2/ja not_active Expired - Lifetime
- 1995-06-16 MX MX9606492A patent/MX9606492A/es unknown
- 1995-06-16 WO PCT/DK1995/000249 patent/WO1995034666A1/en active IP Right Grant
- 1995-06-16 EP EP95922439A patent/EP0763117B1/en not_active Expired - Lifetime
- 1995-06-16 CZ CZ19963641A patent/CZ290069B6/cs not_active IP Right Cessation
- 1995-06-16 PL PL95317722A patent/PL317722A1/xx unknown
- 1995-06-16 CN CN95194183A patent/CN1115413C/zh not_active Expired - Lifetime
- 1995-06-16 DK DK95922439T patent/DK0763117T3/da active
- 1995-06-16 UA UA96124661A patent/UA40648C2/uk unknown
- 1995-06-16 BR BR9508033A patent/BR9508033A/pt not_active IP Right Cessation
- 1995-06-16 PT PT95922439T patent/PT763117E/pt unknown
- 1995-06-16 HU HU9603477A patent/HU221118B1/hu not_active IP Right Cessation
-
1996
- 1996-12-13 FI FI965005A patent/FI965005A/fi unknown
- 1996-12-13 NO NO965362A patent/NO965362L/no unknown
-
1997
- 1997-01-08 US US08/780,571 patent/US5795746A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PL317722A1 (en) | 1997-04-28 |
ES2168367T3 (es) | 2002-06-16 |
DE69523915T2 (de) | 2002-08-22 |
HU221118B1 (en) | 2002-08-28 |
CZ364196A3 (en) | 1997-05-14 |
EP0763117B1 (en) | 2001-11-14 |
MX9606492A (es) | 1997-03-29 |
CN1154143A (zh) | 1997-07-09 |
AU2733495A (en) | 1996-01-05 |
HUT76378A (en) | 1997-08-28 |
PT763117E (pt) | 2002-05-31 |
NO965362D0 (no) | 1996-12-13 |
CN1115413C (zh) | 2003-07-23 |
NO965362L (no) | 1997-02-13 |
DE69523915D1 (en) | 2001-12-20 |
HU9603477D0 (en) | 1997-02-28 |
ATE208823T1 (de) | 2001-11-15 |
US5795746A (en) | 1998-08-18 |
FI965005A0 (fi) | 1996-12-13 |
CZ290069B6 (cs) | 2002-05-15 |
UA40648C2 (uk) | 2001-08-15 |
US5639642A (en) | 1997-06-17 |
EP0763117A1 (en) | 1997-03-19 |
JPH10501413A (ja) | 1998-02-10 |
KR100251054B1 (ko) | 2000-04-15 |
DK0763117T3 (da) | 2002-02-18 |
FI965005A (fi) | 1997-02-13 |
JP3676369B2 (ja) | 2005-07-27 |
WO1995034666A1 (en) | 1995-12-21 |
AU693569B2 (en) | 1998-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508033A (pt) | Cassete de expressão de dna vetor de expressão de levedura célula de levedura processo para produzir um polipeptídeo em levedura | |
EP0824148A3 (en) | Polyester synthase gene and process for producing polyester | |
CA2168429A1 (en) | Expression of fusion polypeptides transported out of cytoplasm without leader sequences | |
CA2263889A1 (en) | P-selectin ligand proteins | |
DE69929805D1 (de) | Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert | |
NZ506748A (en) | Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production | |
ATE302851T1 (de) | Verbesserter klonierungsvektor mit markerinaktivierungssystem | |
EP1380648A3 (en) | Recombinant DNAase B derived from streptococcus pyogenes | |
CA2252493A1 (en) | .beta.-galactoside - .alpha. 2,6-sialyltransferase gene | |
CA2238296A1 (en) | Ultrathermostable protease genes | |
US5151509A (en) | Gene encoding serine protease inhibitor | |
WO1995030001A3 (en) | Novel p-selectin ligand protein | |
EP0780471A3 (en) | Novel nitrilase gene | |
EP0933427A3 (en) | Beta-carotene hydroxylase gene | |
DK1196560T3 (da) | Neurotrofisk faktor receptor GFR-alfa-4 | |
KR950701345A (ko) | 엘라스타제 저해활성을 갖는 신규 펩티드 및 그의 제조방법 | |
EP0845536A3 (en) | Protein having ethylenediamine-N,N'-disuccinic acid: ethylenediamine lyase activity and gene encoding the same | |
Kuchinke | 50 Residues coded by exon 2 of chicken lysozyme carry residual catalytic activity | |
EP0897984A3 (en) | D-Sorbitol dehydrogenase gene | |
WO1997031104A3 (en) | Candida albicans profilin gene | |
WO2003057887A1 (fr) | Nouvelles transferases udp-n-acetyl-d-galactosamine :polypeptide n-acetylgalactosamine et acides nucleiques codant ces dernieres | |
TH37378A (th) | " ยีนเพลนิซิลลินเอซิเสและโปรตีนที่ประมวลรหัสไว้ในยีนดังกล่าวและสายพันธ์ B.megaterium ที่มีดีเอ็นเอสายผสมที่มียีนเพลนิซิลินเอซิเลส " | |
AU2003219319A1 (en) | Novel fluorescent proteins containing fqygf in the chromophore | |
TH37378EX (th) | " ยีนเพลนิซิลลินเอซิเสและโปรตีนที่ประมวลรหัสไว้ในยีนดังกล่าวและสายพันธ์ B.megaterium ที่มีดีเอ็นเอสายผสมที่มียีนเพลนิซิลินเอซิเลส " |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
HKFN | Application deemed withdrawn (deleted) | ||
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
FF | Decision: intention to grant | ||
FG9A | Patent or certificate of addition granted | ||
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 16/06/2015 |